Results of peripheral vasculopathy, which include Raynaud’s phenomenon, ended up noticed in postmarketing experiences and in the therapeutic dosages of CNS stimulants in all age teams throughout the class of therapy. Signs and signs and symptoms frequently enhanced just after dosage reduction or discontinuation from the CNS stimulant.Li?u dùng c